| Secondary |
| Hypertension |
54.5% |
| Product Used For Unknown Indication |
9.3% |
| Diabetes Mellitus |
5.0% |
| Drug Use For Unknown Indication |
4.5% |
| Pain |
3.9% |
| Prophylaxis |
3.8% |
| Hypercholesterolaemia |
2.5% |
| Nephrogenic Anaemia |
1.8% |
| Type 2 Diabetes Mellitus |
1.8% |
| Infarction |
1.5% |
| Depression |
1.3% |
| Oligodendroglioma |
1.3% |
| Osteoporosis |
1.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.3% |
| Thrombosis Prophylaxis |
1.3% |
| Constipation |
1.1% |
| Immunosuppression |
1.1% |
| Dyspepsia |
1.0% |
| Incontinence |
1.0% |
| Ischaemic Heart Disease Prophylaxis |
1.0% |
|
| Syncope |
20.3% |
| Renal Impairment |
8.9% |
| Strabismus |
8.9% |
| Subileus |
7.6% |
| Arrhythmia |
5.1% |
| Hepatic Neoplasm Malignant Recurrent |
5.1% |
| Headache |
3.8% |
| Hyperkalaemia |
3.8% |
| Leukocytoclastic Vasculitis |
3.8% |
| Myalgia |
3.8% |
| Prothrombin Time Abnormal |
3.8% |
| Stillbirth |
3.8% |
| Viith Nerve Paralysis |
3.8% |
| Blood Urea Increased |
2.5% |
| Cardiac Pacemaker Insertion |
2.5% |
| Drug Interaction |
2.5% |
| Fall |
2.5% |
| General Physical Health Deterioration |
2.5% |
| Hypertension |
2.5% |
| Hypoglycaemia |
2.5% |
|
| Concomitant |
| Hypertension |
39.8% |
| Product Used For Unknown Indication |
18.7% |
| Drug Use For Unknown Indication |
11.5% |
| Diabetes Mellitus |
4.0% |
| Type 2 Diabetes Mellitus |
2.8% |
| Coronary Artery Disease |
2.4% |
| Prophylaxis |
2.3% |
| Prophylaxis Against Transplant Rejection |
2.1% |
| Atrial Fibrillation |
1.8% |
| Renal Transplant |
1.8% |
| Rheumatoid Arthritis |
1.7% |
| Hypercholesterolaemia |
1.6% |
| Pain |
1.4% |
| Pneumonia |
1.4% |
| Hyperparathyroidism Secondary |
1.3% |
| Hyperuricaemia |
1.1% |
| Depression |
1.1% |
| Diffuse Large B-cell Lymphoma |
1.1% |
| Cardiac Failure |
1.1% |
| Prostate Cancer |
1.1% |
|
| Vomiting |
13.3% |
| Urinary Retention |
6.9% |
| Renal Failure Acute |
6.4% |
| Renal Failure |
6.0% |
| Hyponatraemia |
5.6% |
| Syncope |
5.6% |
| Weight Decreased |
5.2% |
| Weight Increased |
5.2% |
| Nausea |
4.7% |
| Pneumonia |
4.7% |
| Shock Hypoglycaemic |
4.7% |
| Renal Impairment |
4.3% |
| Pulmonary Embolism |
3.9% |
| Urinary Tract Infection |
3.9% |
| Drug Interaction |
3.4% |
| Hypertension |
3.4% |
| Pain |
3.4% |
| Thrombocytopenia |
3.4% |
| Death |
3.0% |
| Malaise |
3.0% |
|
| Interacting |
| Hypertension |
50.5% |
| Infarction |
9.5% |
| Pain |
7.6% |
| Type 2 Diabetes Mellitus |
5.7% |
| Prophylaxis |
4.8% |
| Thrombosis Prophylaxis |
4.8% |
| Cerebrovascular Accident |
3.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
3.8% |
| Hyperuricaemia |
2.9% |
| Arrhythmia Prophylaxis |
1.9% |
| Cardiac Failure |
1.9% |
| Hypercholesterolaemia |
1.9% |
| Drug Use For Unknown Indication |
1.0% |
|
| Syncope |
45.5% |
| Vomiting |
27.3% |
| Renal Failure Acute |
18.2% |
| Constipation |
9.1% |
|
